small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (226)
  • Capabilities (56)
  • Experience (20)
  • Insights & News (1,255)
  • Other Results (36)

Professionals 226 results

Eva Cole
Eva Cole
Partner
  • New York
Email
+1 212-294-4609
vCard

Partner

  • New York
Jeffrey Kessler
Jeffrey Kessler
Partner
  • New York
Email
+1 212-294-4698
vCard

Partner

  • New York
Jim Herbison
Jim Herbison
Partner
  • Chicago
Email
+1 312-558-5909
vCard

Partner

  • Chicago
View All Professionals

Capabilities 56 results

Practice Area

Antitrust/Competition

Practice Area

Technology Antitrust

As society and business become even more digitalized, technology and intellectual property (IP) have become key focal points for businesses. Our Technology Antitrust Group combines the cross-practice and cross-office experience of our lawyers to assist clients in successfully navigating the dynamic convergence of technology, antitrust, and IP law. We understand the challenges presented by the ever-changing digital landscape and are committed to providing our clients with tailored solutions to address their specific needs....Read more

Practice Area

Antitrust Transactions

   

Experience 20 results

Experience

|

April 30, 2025

Rapid Ruling: Fifth Circuit Affirms Winston Win on Summary Judgment the Day After Oral Argument

Experience

|

March 18, 2025

Winston Blunts Earnout Payment

Experience

|

January 31, 2025

Winston Secures Complete Defense Judgment for Alphatec in Prolonged Litigation Battle

View All Experience

Insights & News 1,255 results

In the Media

|

August 21, 2025

|

2 Min Read

Aparna Sehgal Discusses European CRE Recovery with Structured Credit Investor

Winston & Strawn partner Aparna Sehgal spoke with Structured Credit Investor to discuss the findings of the Bayes Business School’s latest European Commercial Real Estate Lending report and the legal issues and trends underpinning them. In addition to valuable data on deal volumes and covenant and pricing terms, the report on European real estate debt markets offers insight into how underlying funding structures and bank participation through the repo/loan-on-loan market are shaping the recovery of different real estate markets at a national and sector level. According to the report, U.K. property values and deal activity have rebounded faster, while European markets remain challenged by a mix of stalled development sales, rising capital costs, and stricter environmental upgrade requirements hold back volumes....Read more

Recognitions

|

August 15, 2025

|

Less Than 1 Min Read

Winston Partners Named to Benchmark Litigation’s 2025 List of the Top 250 Women in Litigation

Five Winston & Strawn partners were named among Benchmark Litigation’s 2025 Top 250 Women in Litigation. Honorees earned their place on the list through their significant contributions to “the most impactful litigation matters in recent history” and by garnering the trust and respect of their clients and peers....Read more

Recognitions

|

August 12, 2025

|

Less Than 1 Min Read

Winston Partners Named to Benchmark Litigation’s 2025 40 & Under List

Winston & Strawn is proud to announce that 13 partners have been recognized on the 2025 Benchmark Litigation 40 & Under List. The annual list aims to recognize the best and brightest litigators under the age of 40 across the United States and Canada. These young ambitious and accomplished lawyers are among the top young talent in their respective litigation communities and frequently handle major cases – some of which are high-stakes or precedent-setting....Read more
View All Insights & News

Other Results 36 results

Site Content

What Is the California Unfair Competition Law?

California Unfair Competition Law...Read more

Europe

Site Content

What Is the BPCIA?

Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) to provide an abbreviated pathway for biosimilars to gain FDA approval through submission of an abbreviated Biologics License Application (aBLA)....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising